MAPT and Alzheimer disease: Published reports indicate that APOE polymorphisms are associated with AD pathophysiology involving the plaque deposition of intraneuronal amyloid-β (Aβ) aggregates, and hyperphosphorylated tau-mediated neurodegeneration (Yamazaki et al., 2019).